Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

Dr. Stéphane Roche, PhD
Founder and CEO at AdaptBio Therapeutics
Speaker

Profile

Stéphane is the founder and CEO of AdaptBio Therapeutics (Est. in 2024). He has 15+ years of experience in synthetic and medicinal chemistry in diverse therapeutic areas, working on small-molecule natural products and peptide drugs. Stéphane is also a faculty at Florida Atlantic University, where he works on a variety of peptide drug discovery and preclinical development programs focusing on protein-protein interactions. Stéphane received a Ph.D. in Organic Chemistry from the Blaise Pascal University (France) and conducted post-doctoral studies at the @Star ICES Institute (Singapore) and at Boston University in the field of natural product total synthesis.

Agenda Sessions

  • ADAPT: An Emerging Platform of Antibody CDR-H3 Peptide Scaffolds in the Landscape of Protein-Protein Interaction Inhibitors

    , 11:45am
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Stéphane at TIDES USA: Oligonucleotide & Peptide Therapeutics